Thérapie photodynamique
Thérapie photodynamique
Bloc opératoire
Thérapie photodynamique
Thérapie photodynamique
Thérapie photodynamique
Laser therapies

LASER ASSISTED THERAPIES AND IMMUNOTHERAPIES FOR ONCOLOGY

Glioblastoma

GLIOBLASTOMA

Malignant Pleural Mesothelioma

MALIGNANT PLEURAL MESOTHELIOMA

Actinic Keratosis

ACTINIC KERATOSIS & PAGET DISEASE

Peritoneal carcinomatosis

PERITONEAL CARCINOMATOSIS

Immunotherapy

IMMUNOTHERAPY

previous arrow
next arrow

Defense of Laurine Nieuwjaer Ziane thesis - September 26, 2023

Laurine Ziane defended her PhD thesis entitled « Develepment of a light emitting device for the treatment of ovarian peritoneal carcinomatosis by intracavitary photodynamic therapy »

Publication of French standard NF G20-030: Luminous textiles - Determination of the irradiance and luminance of luminous fabrics

 French standard NF G20-030: Luminous textiles - Determination of the irradiance and luminance of luminous fabrics has just been published. OncoThAI, in particular, Elise THECUA, participated in [...]

A facile fabrication of dissolving microneedles containing 5-aminolevulinic acid

The article entitled "A facile fabrication of dissolving microneedles containing 5-aminolevulinic acid" By Mathilde CHAMPEAU and al is now online. This project is performed thanks to a collaboration [...]

All news

OncoThAI represented by

INSERM 1189 Onco Thai
Pr. Nadira Delhem
Bâtiment OncoLille
Frédéric Combemale
59000 Lille
Phone:  +33 320 446 709

Webdesign and Webhosting:

Staminic / OVH

Email

This website has been created, and is maintained, by Staminic on behalf of OncoThAI. The following are the terms and conditions of use of this website, and if you do not accept these you must not use the website. Use of this website is taken to mean that you have accepted these terms and conditions.

Contents

The information contained in this website is intended for general information only. OncoThAI makes no representation or warranty as to the accuracy or availability of such information, and shall not be responsible in any way for any use of or reliance on such information by any person. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.

All offers are not-binding and without obligation. Parts of the pages or the complete publication including all offers and information might be extended, changed or partly or completely deleted by the author without separate announcement.

OncoThAI makes no representation or warranty that use of this website, or materials downloaded from it, will not cause computer virus infection or other damage to property. You are advised to ensure that you have adequate measures to prevent any such problems.

External Links:

OncoThAI is not responsible for any sites that may be accessed from links contained in this website, and makes no representation or warranty as to their availability, or the suitability or accuracy of their content. If you choose to link to these sites you do so at your own risk.

Coyright Notice

You are welcome to make a link to any of the OncoThAI web pages on the internet. There is no need to request permission.

The pictures on this page come INSERM and are licensed for use under the copyright law.

Privacy Policy and Statistics

If the opportunity for the input of personal or business data (email addresses, name, addresses) is given, the input of these data takes place voluntarily. The use and payment of all offered services are permitted - if and so far technically possible and reasonable - without specification of any personal data or under specification of anonymized data or an alias. The use of published postal addresses, telephone or fax numbers and email addresses for marketing purposes is prohibited; offenders sending unwanted spam messages will be punished.

We collect web statistics automatically about your visit to our site. This information is used to aid development of the website and its content and to audit usage of the site. The information gathered in this way will not be used for any other purpose. These statistics do not contain personal data and cannot be traced back to an individual.

This website reflects only the author's views and the Community is not liable for any use that may be made of the information contained therein.

Press release

Innovative laser technology to treat glioblastomas: Download the press release21.58 MB (October 2017) 


Images to download

DSC2580
DSC2581
DSC2577
DSC2574
DSC2571
DSC2569
DSC2559
DSC2549
DSC2555
DSC2540
DSC2535
DSC2530
DSC2528
DSC2527
DSC2524
DSC2516
DSC2510
DSC2507
DSC2503
DSC2488
DSC2485
DSC2471
DSC2470
DSC2461
DSC2460
DSC2457
DSC2411
DSC2400
DSC2410
 

Download the images archive86.12 MB


INDYGO clinical trial overview

Download the press review 13.81 MB [French only] (September - October 2017)

Download the Nature Outlook 1.02 MB (September 27, 2018)

The project ONCO-THAI aims to develop minimally invasive therapies based on light and medical imaging

This project leads to the development of technical platforms (hardware and software). These platforms integrate results obtained on mathematical modeling of light-tissue interaction (LITT: Laser Interstitial Thermo-Therapy and PDT: Photodynamic Therapy) and on medical imaging for the identification of cancer foci  using Mutimodality Imaging iii) simulation, planning and monitoring of treatment procedures.

Main research programs concern

The project is divided in two sub-themes: Focal interstitial laser therapy for prostate cancer, brain (glioblastoma) and Intracavity  laser therapy for peritoneal carcinoses or mesothelioma.

Light Efficiency Calculator

Photodynamic therapy is a well-established treatment for various dermatological diseases including actinic keratoses (AK).

Although the clinically approved protocols for PDT of AK require irradiation with red light or daylight in Europe and with blue light in USA, there is a growing interest in other lights particularly in white lights.

Light sources can be characterized by various quantities : illuminance (lux), irradiance (W/cm²), effective irradiance (W/cm²). 
To compare the consistency of the light sources, it may be necessary to switch from one quantity to another. We have therefore developed a computer software "Light Efficiency Calculator for PpIX PDT" that, from any spectral irradiance automatically and instantly displays the values of the illuminance, the irradiance and the effective irradiance.

This software has been filed with the computing program protection agency and is avalaible online : http://www.oncothai.fr/light-efficiency-calculator/index.php


Dicom viewer RT

The “radiotherapy structure set” (RTSTRUCT) object of the DICOM standard is used for the transfer of patient structures and related data. It contains mainly the information for regions of interest (ROIs) and points of interest.

For futher informations, please refer to the DICOM NEMA standard here.

The Inserm U1189 OncoThAI unit developed tools for viewing dicom images and RT-STRUCT dicom images.

Dicom viewer RT

Download the software6.92 MB

Brochures

Dermato PDT DermatoPDT

MesoPDT MesoPDT

NeuroPDT NeuroPDT

Prodynov Prodynov

ImmunoPDT ImmunoPDT

Newsletter

pdfDownload newsletter October 2018 [French]

pdfDownload newsletter December 2018 [French]

pdfDownload newsletter September 2019 [French]

pdfDownload newsletter June 2020 [French]

OncoThAI "Laser Assisted Therapies and Immunotherapies for Oncology" is directed by Pr. Nadira DELHEM.

This laboratory (INSERM, University of Lille, CHU) is composed of 2 teams:

OncoThAI develops an innovative therapy, Photodynamic Therapy (PDT), essentially for cancers that have reached a therapeutic impasse.

Indeed, the use of PDT in oncology has been of growing interest for several years.

This property would be a major asset in oncology considering the revolutionary success of anti-tumor immunotherapies over the last 3 years. Based on this rationale, the activities of the ImmunoPDT team aim to develop fundamental and translational clinical projects to characterize the effects of PDT, used alone or in combination with conventional therapies, on the regulation of the immune response.

PhysicoPDT develops the technologies required for the implementation of PDT in human clinics. In addition to mathematical modelling of mechanisms (in-silico studies), the team has recognized expertise in treatment planning, simulation, light dosimetry and medical device design.

Finally, the team relies on proven expertise in the implementation of clinical protocols to evaluate PDT, in particular thanks to a very strong involvement of clinicians within OncoThAI.

HCERES2020

Vidéos

OncoThAI YouTube channel